Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.2K
Immunological Memory01:23

Immunological Memory

15.0K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
15.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare Mobility among United States Military Veterans with Experience of Housing Instability.

Community mental health journal·2026
Same author

Understanding Influencers of Decision-Making Behaviors Towards Advance Care Planning Among Chronic Kidney Disease Dyads: A Qualitative Descriptive Secondary Data Analysis.

Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association·2026
Same author

Distance to Care, Regional Context, and Survival in Early-Onset Colorectal Cancer.

Journal of surgical oncology·2026
Same author

Compact non-line-of-sight imager at long range.

Optics express·2026
Same author

Valorization of coffee Silverskin into a novel dietary Fiber ingredient: A comprehensive study on structure, and in vitro/in vivo antioxidant activity.

Food research international (Ottawa, Ont.)·2026
Same author

Group A Streptococcus Disease Outbreak Associated with Large Congregate Shelter, Chicago, Illinois, USA, October 2023-January 2024.

Emerging infectious diseases·2026

Related Experiment Video

Updated: Jan 12, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

553

COVID-19 Reinfection in Children With Cancer: Clinical Course and Risk Factors.

Pietro Miozzo1,2,3, Joseph-Michael Fields3, Chen Dai4

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Pediatric Blood & Cancer
|November 5, 2025
PubMed
Summary
This summary is machine-generated.

COVID-19 reinfection in children with cancer occurred in 6% of cases. Subsequent infections did not reduce severity or impact cancer treatment, highlighting the need for prevention strategies.

Keywords:
COVIDcancerchildpediatricreinfectionsecond infection

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 12, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

553
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • COVID-19 Research

Background:

  • Children with cancer face a higher risk of severe COVID-19.
  • Data on COVID-19 reinfection rates and outcomes in this vulnerable population are limited.

Purpose of the Study:

  • To investigate the incidence and characteristics of COVID-19 reinfection in pediatric cancer patients.
  • To determine if reinfection impacts disease severity or cancer treatment.

Main Methods:

  • Analysis of data from the Pediatric Oncology COVID-19 case report.
  • Inclusion of 2075 infections in children (≤21 years) receiving cancer-directed therapy.
  • Examination of factors associated with reinfection and outcomes.

Main Results:

  • Reinfection accounted for 6% of all COVID-19 infections in the study cohort.
  • Children with reinfection showed no lower odds of hospitalization, ICU admission, or treatment changes.
  • Hematologic malignancies were associated with higher odds of reinfection.
  • Reinfection did not lead to a less severe disease course compared to the initial infection.

Conclusions:

  • COVID-19 reinfection is a notable event in children undergoing cancer therapy.
  • Reinfection does not appear to mitigate disease severity or disrupt cancer treatment.
  • Preventing reinfection is crucial for this high-risk pediatric population.